Agilent launches BioTek Cytation 9 cell imaging reader

Agilent Technologies has announced the launch of its BioTek Cytation 9 system, merging multimode microplate reading and high-content cell imaging into a single platform. This new instrument builds upon the company's established Cytation product line, aiming to accelerate laboratory workflows from sample analysis to actionable insights.

The Cytation 9 is designed for researchers conducting both cell-based and biochemical assays. It features enhanced imaging capabilities, including inverted fluorescence microscopy, upright imaging, and a multimode microplate reader module. Agilent states the device supports a diverse range of applications, from basic research to high-content screening workflows.

Since its initial introduction in 2013, the BioTek Cytation portfolio has been a key offering for Agilent. The company reports that the new Cytation 9 is designed to meet evolving research demands, particularly within pharmaceutical and biotechnology laboratories. The instrument is intended to offer faster, higher-throughput solutions for advanced cell models used in disease and drug discovery research.

Xavier Amouretti, Vice President and Business Unit Leader for BioTek and Seahorse at Agilent, indicated that the Cytation 9 was developed based on extensive customer feedback. He noted that the new system provides a broader application range and twice the imaging speed compared to its predecessors, which is expected to accelerate discoveries in cell biology and drug development.